Cognex (NASDAQ:CGNX) Sets New 52-Week High Following Better-Than-Expected Earnings

Shares of Cognex Corporation (NASDAQ:CGNX) hit a new 52-week high during mid-day trading on Wednesday following a better than expected earnings announcement. The stock traded as high as $61.40 and last traded at $61.3680, with a volume of 430163 shares. The stock had previously closed at $58.83.

The scientific and technical instruments company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.25 by $0.09. The firm had revenue of $268.44 million for the quarter, compared to analyst estimates of $245.98 million. Cognex had a return on equity of 10.86% and a net margin of 13.62%.Cognex’s revenue for the quarter was up 24.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.14 EPS. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS.

Cognex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 4th. Shareholders of record on Thursday, May 21st will be issued a $0.085 dividend. The ex-dividend date is Thursday, May 21st. This represents a $0.34 dividend on an annualized basis and a yield of 0.5%. Cognex’s payout ratio is currently 40.48%.

Trending Headlines about Cognex

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Q1 beat and upbeat Q2 guide — Cognex reported Q1 revenue up ~24% and EPS of $0.34 (vs. Street ~ $0.25), with margin expansion and management citing broad-based demand plus new AI-powered In-Sight vision systems; Q2 guidance of $280–$300M revenue and $0.40–$0.44 EPS points to continued momentum. CGNX Q1 Earnings Beat Estimates on Broad-Based Demand Strength
• Positive Sentiment: Analyst upgrades lift sentiment — Stephens and Needham raised price targets to $75 and issued overweight/buy calls, signaling Wall Street is pricing in further upside from automation and logistics demand. Cognex (NASDAQ:CGNX) Given New $75.00 Price Target at Stephens Needham raises target to $75
• Positive Sentiment: Elevated call option activity — unusually large call volume (over 9k contracts) shows speculative/hedged bullish positioning around the earnings/guidance beat, which can amplify intraday upside.
• Neutral Sentiment: Dividend declared — board approved a $0.085 quarterly dividend (ex‑dividend May 21, payable June 4). Small yield; supportive but not a major driver.
• Neutral Sentiment: Market coverage and valuation debate — commentary and deep-dive pieces are asking whether the post‑surge rally (roughly +121% one year) leaves upside limited, prompting mixed investor views on near-term buy-in. Is It Too Late To Consider Cognex (CGNX) After A 121% One Year Surge?
• Negative Sentiment: Insider selling and high valuation — recent filings show multiple insider sales in the past six months; combined with a stretched P/E (~78x) after the rally, this raises risk that expectations are high and could weigh on the stock if growth normalizes. Cognex shares jump on Q1 beat and upbeat Q2 outlook

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Truist Financial set a $61.00 price target on Cognex and gave the stock a “hold” rating in a research note on Friday. Sanford C. Bernstein restated an “outperform” rating and set a $75.00 price objective on shares of Cognex in a report on Thursday. Zacks Research lowered Cognex from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 14th. JPMorgan Chase & Co. raised their price target on shares of Cognex from $55.00 to $65.00 and gave the stock a “neutral” rating in a research report on Friday. Finally, Wall Street Zen lowered shares of Cognex from a “buy” rating to a “hold” rating in a research note on Saturday, April 11th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $65.00.

Insiders Place Their Bets

In other news, VP Laura Ann Macdonald sold 14,881 shares of Cognex stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $57.16, for a total value of $850,597.96. Following the completion of the transaction, the vice president owned 2,212 shares in the company, valued at approximately $126,437.92. This trade represents a 87.06% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Angelos Papadimitriou sold 4,150 shares of the stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $55.58, for a total transaction of $230,657.00. Following the sale, the director directly owned 16,222 shares in the company, valued at $901,618.76. This trade represents a 20.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 196,083 shares of company stock valued at $11,419,321 in the last quarter. Insiders own 1.70% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Quent Capital LLC bought a new stake in shares of Cognex in the 3rd quarter worth $26,000. REAP Financial Group LLC acquired a new position in Cognex during the third quarter worth about $27,000. Geneos Wealth Management Inc. grew its holdings in Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after acquiring an additional 736 shares during the period. CIBC Private Wealth Group LLC raised its position in Cognex by 74.8% in the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock worth $35,000 after acquiring an additional 327 shares in the last quarter. Finally, Cassaday & Co Wealth Management LLC acquired a new stake in Cognex in the 1st quarter valued at about $36,000. 88.12% of the stock is owned by institutional investors and hedge funds.

Cognex Trading Up 0.6%

The company’s 50-day moving average price is $52.67 and its two-hundred day moving average price is $45.20. The company has a market cap of $11.08 billion, a P/E ratio of 78.79 and a beta of 1.48.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.